Zhao Lijian, Qu Yuqing, Zhang Yanshu, Zou Zhaolei, Lu Jingyi, Wang Zhi, Li Bin, Fang Juan
Hospital of Stomatology, Guanghua School of Stomatology, Guangdong Provincial Key Laboratory of Stomatology, Sun Yat-Sen University, 56 Lingyuan Road West, Guangzhou, 510055, Guangdong, China.
Clinical Trials Unit, First Affiliated Hospital of Sun Yat-Sen University, No. 58, Zhongshan Er Road, Guangzhou, Guangdong, 510080, China.
Heliyon. 2024 Oct 16;10(20):e39408. doi: 10.1016/j.heliyon.2024.e39408. eCollection 2024 Oct 30.
The study aims to present an observational study of clinical trials on Oral Potentially Malignant Disorders (OPMDs) and corresponding publications.
We searched the OPMDs-related clinical studies registered in the ClinicalTrials.gov database before March 1, 2024. Subsequently, we investigated the publication status of primary completed studies using PubMed and Google Scholar.
A total of 185 studies were identified for analysis, including 141 interventional studies and 44 observational studies. The most commonly studied disease type was oral lichen planus (OLP), accounting for 113 studies (61.1 %). Interventional studies on OPMDs were predominantly early-phased, blind, randomized, parallel and single-center. The primary purpose of these studies was treatment (106, 75.2 %). Among the treatments, herbal medicine (21, 19.8 %), photodynamic therapy (17, 16.0 %), and glucocorticoids (14, 13.2 %) were of greatest interest. In addition, 58 (63.0 %) of the primarily completed interventional studies were published, with a median time to publication of 33.6 months. Published interventional studies including OLP patients and factorial designs had shorter time to publication. However, these studies were less frequently published in high-impact journals and most primary results were positive.
Clinical trials on OPMDs predominantly focused on OLP and herbal medicine. The quality of studies is unsatisfactory and publication rate is suboptimal. Improvements are needed in ClinicalTrials.gov registration standards, high-quality study design and more stringent publishing requirements.
本研究旨在对口腔潜在恶性疾病(OPMDs)的临床试验及相应出版物进行观察性研究。
我们检索了截至2024年3月1日在ClinicalTrials.gov数据库中注册的与OPMDs相关的临床研究。随后,我们使用PubMed和谷歌学术搜索调查了主要完成研究的发表情况。
共确定185项研究进行分析,包括141项干预性研究和44项观察性研究。研究最常见的疾病类型是口腔扁平苔藓(OLP),占113项研究(61.1%)。OPMDs的干预性研究主要为早期、盲法、随机、平行和单中心研究。这些研究的主要目的是治疗(106项,75.2%)。在治疗方法中,草药(21项,19.8%)、光动力疗法(17项,16.0%)和糖皮质激素(14项,13.2%)最受关注。此外,58项(63.0%)主要完成的干预性研究已发表,发表的中位时间为33.6个月。纳入OLP患者和析因设计的已发表干预性研究发表时间较短。然而,这些研究在高影响力期刊上发表的频率较低,且大多数主要结果为阳性。
OPMDs的临床试验主要集中在OLP和草药方面。研究质量不尽人意,发表率也不理想。需要改进ClinicalTrials.gov注册标准、高质量研究设计和更严格的发表要求。